Growth rate-corrected (GR) dose-response metrics across a panel of 71 breast cancer cell lines treated with a library of small molecule and antibody perturbagens. Dataset 2 of 4: Calculated dose-response metrics. - Dataset (ID:20269)

Filter results: >>>>
Cell Clinical Subtype Transcriptional Subtype Small Molecule Antibody Perturbagen Target Perturbagen Class Biological Replicate ID Conc Unit GR50 GEC50 GRmax GRinf GR Hill Coefficient GR_AOC GR r2 Nominal Division Rate
HCC1419
HER2amp
Luminal
Bortezomib
Proteasome
Proteasome
7440.074
uM
0.02565
0.04838
-0.9985 -0.9930 1.7238 1.2828
0.9922
0.4778
HCC1419
HER2amp
Luminal
Bortezomib
Proteasome
Proteasome
7440.074
uM
0.02565
0.04838
-0.9985 -0.9930 1.7238 1.2828
0.9922
0.4778
HCC1419
HER2amp
Luminal
Bortezomib
Proteasome
Proteasome
7437.074
uM
0.03991
0.04961
-0.9997 -0.9835 5.0000 1.2451
0.9986
0.3747
HCC1419
HER2amp
Luminal
Bortezomib
Proteasome
Proteasome
7437.074
uM
0.03991
0.04961
-0.9997 -0.9835 5.0000 1.2451
0.9986
0.3747
HCC1419
HER2amp
Luminal
Bromopyruvic acid
Hexokinase II
Metabolism
12612.177
uM
0.27633
0.59194
-0.9998 -1.0000 1.4421 0.7563
0.9436
0.5119
HCC1419
HER2amp
Luminal
Carboplatin
DNA cross-linker
DNA cross-linker
7820.011
uM
88.88780
144.89250
-0.9365 -0.9506 2.1798 0.3160
0.9953
0.6709
HCC1419
HER2amp
Luminal
Carboplatin
DNA cross-linker
DNA cross-linker
10019.12
uM
43.09170
78.77850
-0.9916 -0.9762 1.7945 0.4068
0.9964
0.4898
HCC1419
HER2amp
Luminal
Carboplatin
DNA cross-linker
DNA cross-linker
7819.075
uM
93.440
159.4530
-0.9166 -0.9434 1.9836 0.3035
0.9969
0.5386
HCC1419
HER2amp
Luminal
Carboplatin
DNA cross-linker
DNA cross-linker
9278.011
uM
58.14860
105.43350
-0.9721 -0.9845 1.8287 0.3704
0.9976
0.5434
HCC1419
HER2amp
Luminal
Cetuximab
EGFR
ErbB
7820.042
uM
inf
inf
1.0221 1.0221 0.0000 -0.0483
-28.6122
0.5216
HCC1419
HER2amp
Luminal
Cetuximab
EGFR
ErbB
10019.124
uM
inf
inf
0.9810 0.9810 0.0000 -0.0457
-3.7312
0.5356
HCC1419
HER2amp
Luminal
Cetuximab
EGFR
ErbB
7818.018
uM
inf
inf
0.8205 0.8205 0.0000 0.1029
-0.1580
0.9928
HCC1419
HER2amp
Luminal
Cetuximab
EGFR
ErbB
7821.042
uM
inf
inf
0.7843 0.7843 0.0000 0.1193
-0.0824
0.5522
HCC1419
HER2amp
Luminal
Cetuximab
EGFR
ErbB
9278.026
uM
inf
inf
0.8659 0.8659 0.0000 0.0594
-0.0671
0.3395
HCC1419
HER2amp
Luminal
CGC-11047
Polyamine analogue
7818.018
uM
43.14510
395.0930
-0.9231 -1.0000 0.4961 0.5311
0.8727
0.9928
HCC1419
HER2amp
Luminal
CGC-11047
Polyamine analogue
10019.124
uM
6.80690
30.23160
-0.9945 -1.0000 0.7369 0.5217
0.9114
0.5356
HCC1419
HER2amp
Luminal
CGC-11047
Polyamine analogue
9278.026
uM
1.04710
16.32940
-1.0000 -1.0000 0.3999 0.9084
0.9403
0.3395
HCC1419
HER2amp
Luminal
Chloroquine
12612.177
uM
3.48190
13.34580
-0.8059 -1.0000 0.8177 0.4240
0.8498
0.5119
HCC1419
HER2amp
Luminal
Cisplatin
DNA cross-linker
DNA cross-linker
10019.049
uM
inf
inf
1.0500 1.0500 0.0000 -0.0250
-0.1954
0.4626
HCC1419
HER2amp
Luminal
Cisplatin
DNA cross-linker
DNA cross-linker
7820.017
uM
7.99380
16.98340
-0.9572 -0.9743 1.4350 0.4528
0.9802
0.6915
HCC1419
HER2amp
Luminal
Cisplatin
DNA cross-linker
DNA cross-linker
9278.017
uM
11.51060
25.01950
-0.9897 -1.0000 1.4150 0.3506
0.9950
0.5453
HCC1419
HER2amp
Luminal
Cisplatin
DNA cross-linker
DNA cross-linker
7821.017
uM
10.94250
15.93540
-0.9918 -0.9887 2.9026 0.4020
0.9954
0.3792
HCC1419
HER2amp
Luminal
CPT-11
TOP1
TOP
7821.007
uM
8.44820
29.69020
-0.4350 -1.0000 0.8741 0.3180
0.8791
0.6838
HCC1419
HER2amp
Luminal
CPT-11
TOP1
TOP
9278.121
uM
22.31750
45.79590
-0.4534 -1.0000 1.5283 0.1211
0.9825
0.4498
HCC1419
HER2amp
Luminal
CPT-11
TOP1
TOP
7820.007
uM
20.30050
23.53010
-0.4963 -0.5031 4.7162 0.0753
0.9929
0.6838